A historic moment for open science: the Yale University Open Data Access project and medtronic.
作者信息
Krumholz Harlan M, Ross Joseph S, Gross Cary P, Emanuel Ezekiel J, Hodshon Beth, Ritchie Jessica D, Low Jeffrey B, Lehman Richard
出版信息
Ann Intern Med. 2013 Jun 18;158(12):910-1. doi: 10.7326/0003-4819-158-12-201306180-00009.
Abstract
摘要
相似文献
1
A historic moment for open science: the Yale University Open Data Access project and medtronic.开放科学的一个历史性时刻：耶鲁大学开放数据访问项目与美敦力公司。
Ann Intern Med. 2013 Jun 18;158(12):910-1. doi: 10.7326/0003-4819-158-12-201306180-00009.
2
Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information?重组人骨形态发生蛋白-2试验的荟萃分析：脊柱外科医生及其患者应如何对待这些信息？
Ann Intern Med. 2013 Jun 18;158(12):912-3. doi: 10.7326/0003-4819-158-12-201306180-00010.
3
The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency.行业资助的临床研究结构的变化：开创数据共享与透明度。
Ann Intern Med. 2013 Jun 18;158(12):914-5. doi: 10.7326/0003-4819-158-12-201306180-00011.
4
Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research.逼近重组人骨形态发生蛋白-2的真相：证据综合、数据共享、同行评审与可重复研究
Ann Intern Med. 2013 Jun 18;158(12):916-8. doi: 10.7326/0003-4819-158-12-201306180-00012.
5
Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.重组人骨形态发生蛋白-2 在脊柱融合中的有效性和危害：系统评价和荟萃分析。
Ann Intern Med. 2013 Jun 18;158(12):890-902. doi: 10.7326/0003-4819-158-12-201306180-00006.
6
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.重组人骨形态发生蛋白-2 用于脊柱融合的安全性和有效性：一项个体参与者数据的荟萃分析。
Ann Intern Med. 2013 Jun 18;158(12):877-89. doi: 10.7326/0003-4819-158-12-201306180-00005.
7
YODA and truth seeking in medicine.约达与医学中的真理探寻。
BMJ. 2013 Jul 2;347:f4251. doi: 10.1136/bmj.f4251.
8
Editorial: Recombinant human bone morphogenetic protein-2.社论：重组人骨形态发生蛋白-2
J Neurosurg Spine. 2013 Feb;18(2):109-10; discussion 110-1. doi: 10.3171/2012.9.SPINE12476. Epub 2012 Nov 30.
9
Seroma observed 6 months after anterior lumbar interbody fusion that included use of recombinant bone morphogenetic protein 2.在包括使用重组骨形态发生蛋白2的腰椎前路椎间融合术后6个月观察到血清肿。
Spine J. 2015 Oct 1;15(10):e33. doi: 10.1016/j.spinee.2015.05.033. Epub 2015 May 27.
10
Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.在 5 项随机对照试验中，比较单节段前路腰椎手术后使用或不使用重组人骨形态发生蛋白-2 对逆行射精的影响：临床文章。
J Neurosurg Spine. 2013 Feb;18(2):112-21. doi: 10.3171/2012.10.SPINE11908. Epub 2012 Nov 30.
引用本文的文献
1
The clinical assessment of studies on orphan drugs in relation to the EMA's authorization marketing decisions in Europe.关于孤儿药研究与欧洲药品管理局（EMA）在欧洲的授权上市决定相关的临床评估。
Front Pharmacol. 2025 Mar 31;16:1558987. doi: 10.3389/fphar.2025.1558987. eCollection 2025.
2
Is open science a double-edged sword?: data sharing and the changing citation pattern of Chinese economics articles.开放科学是一把双刃剑吗？：数据共享与中国经济学文章引用模式的变化
Scientometrics. 2023;128(5):2803-2818. doi: 10.1007/s11192-023-04684-8. Epub 2023 Mar 21.
3
Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports.利培酮和帕利哌酮治疗精神分裂症或双相情感障碍患者的获益和危害：一项涉及个体参与者数据和临床研究报告的荟萃分析。
BMC Med. 2021 Aug 25;19(1):195. doi: 10.1186/s12916-021-02062-w.
4
Does open data boost journal impact: evidence from Chinese economics.开放数据会提升期刊影响力吗：来自中国经济学领域的证据
Scientometrics. 2021;126(4):3393-3419. doi: 10.1007/s11192-021-03897-z. Epub 2021 Feb 14.
5
Inflection Point: Ideas for Accelerating Breakthroughs and Improving Cardiovascular Health.转折点：加速突破与改善心血管健康的理念
Circ Cardiovasc Qual Outcomes. 2020 Dec;13(12):e007615. doi: 10.1161/CIRCOUTCOMES.120.007615. Epub 2020 Nov 17.
6
Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide.个体参与者数据荟萃分析中获取和管理数据集：范围综述与实用指南。
BMC Med Res Methodol. 2020 May 12;20(1):113. doi: 10.1186/s12874-020-00964-6.
7
Availability of Statistical Code From Studies Using Medicare Data in General Medical Journals.综合医学期刊中使用医疗保险数据的研究的统计代码可用性。
JAMA Intern Med. 2020 Jun 1;180(6):905-907. doi: 10.1001/jamainternmed.2020.0671.
8
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement.预测治疗效果异质性的方法（PATH）声明。
Ann Intern Med. 2020 Jan 7;172(1):35-45. doi: 10.7326/M18-3667. Epub 2019 Nov 12.
9
The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration.预测治疗效果异质性的方法（PATH）声明：解释和说明。
Ann Intern Med. 2020 Jan 7;172(1):W1-W25. doi: 10.7326/M18-3668. Epub 2019 Nov 12.
本文引用的文献
1
Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.重组人骨形态发生蛋白-2 在脊柱融合中的有效性和危害：系统评价和荟萃分析。
Ann Intern Med. 2013 Jun 18;158(12):890-902. doi: 10.7326/0003-4819-158-12-201306180-00006.
2
Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.重组人骨形态发生蛋白-2 用于脊柱融合的安全性和有效性：一项个体参与者数据的荟萃分析。
Ann Intern Med. 2013 Jun 18;158(12):877-89. doi: 10.7326/0003-4819-158-12-201306180-00005.
3
Sharing of clinical trial data among trialists: a cross sectional survey.研究者之间临床试验数据共享：一项横断面调查。
BMJ. 2012 Nov 20;345:e7570. doi: 10.1136/bmj.e7570.
4
The importance of clinical trial data sharing: toward more open science.临床试验数据共享的重要性：迈向更开放的科学。
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):238-40. doi: 10.1161/CIRCOUTCOMES.112.965798.
5
Strengthening and opening up health research by sharing our raw data.通过共享原始数据来加强和开放健康研究。
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):236-7. doi: 10.1161/CIRCOUTCOMES.112.965277.
6
Open science and data sharing in clinical research: basing informed decisions on the totality of the evidence.临床研究中的开放科学与数据共享：基于全部证据做出明智决策。
Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):141-2. doi: 10.1161/CIRCOUTCOMES.112.965848.
7
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.美国国立卫生研究院资助的临床试验在 ClinicalTrials.gov 上的发表情况：横断面分析。
BMJ. 2012 Jan 3;344:d7292. doi: 10.1136/bmj.d7292.
8
A model for dissemination and independent analysis of industry data.一个用于行业数据传播与独立分析的模型。
JAMA. 2011 Oct 12;306(14):1593-4. doi: 10.1001/jama.2011.1459.
9
A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.脊柱外科中重组人骨形态发生蛋白-2 试验的批判性评价：新出现的安全性问题和经验教训。
Spine J. 2011 Jun;11(6):471-91. doi: 10.1016/j.spinee.2011.04.023.
Zotero 插件